EUVIMEDEUVIMED entdecken
Crossref

Long-term results of carotid body tumours surgery and predictive analytics on metastatic disease and recurrence

Najibullah I Verdikhanov iD, Andrey V Chupin, Irina E Timina, Zaurbek A Adyrkhaev

Vascular · 2025

DOI: 10.1177/17085381241297067 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Vascular, 2025. Verfasst von Najibullah I Verdikhanov und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of vascular surgery, A.V. Vishnevsky National Medical Research Center of Surgery, Moscow, Russia. Hauptthemen laut MEDLINE: Carotid Body Tumor, Neoplasm Recurrence, Local, Vascular Surgical Procedures. Die Arbeit nennt 11 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The determination of clinico-surgical predictors of carotid body tumour (CBT) metastasizing and/or recurrence.

Methods

Patients with CBT but without a history of its previous treatment who had received inpatient medical aid at a tertiary surgical centre during the period 2011–2021 were retrospectively reviewed to obtain baseline data. Primary endpoints of the study were CBT metastasizing and/or local recurrence after radical surgery (composite endpoint) and overall survival. Secondary endpoint of the study was primary patency of carotid arteries that had been repaired/reconstructed as a result of CBT removal. Suspected predictors of CBT metastasizing/recurrence were young age of CBT onset, positive family history, multifocal paraganglioma, Shamblin type III CBT, carotid bifurcation and/or internal carotid artery (ICA) reconstruction as a result of CBT excision. To detect CBT metastasizing/recurrence, prospective imaging-based whole-body screening was suggested to patients.

Results

Fifty-three patients met the eligibility criteria. The overall survival rate was 100% at a median follow-up time of 68 months (interquartile range [IQR] 27‒104.5 months). The primary patency of repaired carotid arteries ( n = 9) was 88.9% at a median follow-up time of 99 months (IQR 15.5‒116.5 months). Thirty-nine patients underwent the prospective whole-body screening. Eight (20.5%) patients were diagnosed with metastatic disease ( n = 6) or local recurrence ( n = 2). Patients with CBT metastasizing/recurrence were younger at age of CBT onset ( p = .011), more frequently had Shamblin type III CBT ( p = .004) and the necessity for carotid artery repair/reconstruction ( p = .041) than patients without metastasizing/recurrence. These two groups were similar in terms of gender ( p = .682), the prevalence of multifocal paraganglioma ( p = .167) and positive family history ( p = .180). Only the belonging of a CBT to Shamblin type III was defined as a statistically significant predictor of CBT metastasizing/recurrence in both univariable and multivariable binary logistic regression analyses (odds ratio 30; 95% confidence interval: 2.649–339.739; p = .006 and odds ratio 75.409; 95% confidence interval: 1.082–5254.557; p = .046, respectively). Multifocal paraganglioma as a predictor exhibited a strong tendency towards statistical significance ( p = .09 and p = .072, respectively). Other suspected predictors didn’t reach the level of statistical significance either in univariable ( p = .151 for positive family history) or in multivariable ( p = .211 for age of CBT onset; p = .734 for carotid artery reconstruction/repair) binary logistic regression analyses.

Conclusion

Shamblin type III CBT has high potential for metastasizing and recurrence. Patients with Shamblin type III CBT and/or multifocal paraganglioma should be considered for genetic testing as well as preoperative whole-body radiological imaging and long-term postoperative whole-body imaging-based follow-up.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carotid Body TumorNeoplasm Recurrence, LocalVascular Surgical ProceduresHumansMaleFemaleMiddle AgedRetrospective StudiesTime FactorsRisk FactorsTreatment OutcomeAdultRisk AssessmentAgedVascular Patency

Stichwörter der Autor:innen

Carotid body tumourmetastatic diseaseparagangliomarecurrencewhole-body CT

Autor:innen und Institutionen

  • Department of vascular surgery, A.V. Vishnevsky National Medical Research Center of Surgery, Moscow, Russia.

ORCID-Profile: Najibullah I Verdikhanov

Zitieren

APA

Verdikhanov, N. I., Chupin, A. V., Timina, I. E., & Adyrkhaev, Z. A. (2025). Long-term results of carotid body tumours surgery and predictive analytics on metastatic disease and recurrence. Vascular. https://doi.org/10.1177/17085381241297067

Vancouver

Verdikhanov NI, Chupin AV, Timina IE, Adyrkhaev ZA. Long-term results of carotid body tumours surgery and predictive analytics on metastatic disease and recurrence. Vascular. 2025. doi:10.1177/17085381241297067

BibTeX
@article{Verdikhanov2025,
  author = {Verdikhanov, Najibullah I and Chupin, Andrey V and Timina, Irina E and Adyrkhaev, Zaurbek A},
  title = {Long-term results of carotid body tumours surgery and predictive analytics on metastatic disease and recurrence},
  journal = {Vascular},
  year = {2025},
  doi = {10.1177/17085381241297067}
}
Kostenlos starten →